Yours is one of the first posts other than my own that seems to be considering the possibility that AMPE might not deliver. Time to start considering exit strategies rather than betting all on a potential jackpot that might not materialize
What is disappointing is that AMPE management is very tight lip, they are not communicating anything
to investors or to the public. I've been waiting for months to get any kind of news and it looks like a
dead money here with no where to go but down.
If Ampion data were disappointing, shares would have tumbled hard even on insider knowledge. Based on actual prior trial results and based on publications and the science, there is no way Ampion will fail. Results will be announced in less than three weeks and shares will rocket to $20 overnight. And don't forget, Optina results will be right behind. And then Zertane. And ORP.
Don't let the current sellers fool you. They are making the biggest mistake of their lives by selling now. Everybody has waited this long so a few weeks or a few days more is nothing. Let's hope more sellers pound the stock now so we can all buy more cheap before the explosion.
Sentiment: Strong Buy